. (spon. by Robert A. Ulstrom.) We have observed the association of profound hypoglycemia and anterior hypopituitarism in four newborns. All presented with hypoglycemia during the first 30 hours of life, which reached levels less than 10 mg.%.
Rates of 20-30 mg./kg./min. of 20% dextrose were required to maintain glucose levels above 30 mg.%. All infants were products of complicated pregnancies and deliveries and had APGAR scores of five or less at one and five minutes.
Measurements of anterior pituitary function including serum TSH, T4, ACTH, cortisol and growth hormone, in addition to metapyrone and cosyntropin stimulation, revealed anterior panhypopituitarism in three infants and isolated ACTH deficiency in the other. Posterior pituitary function was normal in all cases. Unresponsiveness of TSH to intravenous thyrotropin releasing hormone (TRH) and normal serum prolactin levels further support anterior pituitary dysfunction in contrast to a hypothalamic etiology. Autopsy on one infant revealed no anterior pituitary tissue. The three surviving patients are all doing well on appropriate hormone replacement. Micropenis was present in the one male and all infants showed a widening of the midfacies.
This unappreciated cause of early neonatal hypoglycemia may be related to birth hypoxia or anatomic malformation of the anterior pituitary and its rudiments. These may be more susceptible to events at birth than previously appreciated and consequently this system should be more agressively evaluated in newborns.
ort the development of antibodies to hLH in a patient treated ith hGH for isolated GH deficiency.
nd GH therapy was begun at 8-9/12 years for a diagnosis of isoated GH deficiency. On LRF (luteinizing hormone releasing factor esting, the LH rose from 0.8 to 1.2 ng/ml (LER 960); FSH respons lso was normal. At 11-11/12 years the patient was still prepuertal with undetectable testosterone levels. A repeat LRF test evealed an "apparent" basal plasma LH of 25.4 ng/ml. Further tudies indicated that his serum had antibodies to hLH which hav ersisted for over 2-112 years on growth hormone therapy without he development of significant GH antibodies. l251-hm was bound o his serum in a displacable fashion; hFSH and hTSH displaced his tracer only at doses compatible with contamination of these tandards by hLH. Radioiodinated hFSH, hTSH and hLH-a were not ound; the antibody is directed against the LH-B subunit. The inding capacity of the serum and the equilibrium constant for The secretion of calcitonin (CT) was studied in 17 children, 10 with hypopituitarism and 7 with agoitrous hypothyroidism.
Plasma CT levels were measured by radioimmunoassay in the basal state and following infusion of pentagastftn (0.5 pglkg) and 10 minute infusions of calcium (2.3 mg/kg Ca as CaC1 ) . Of the 10 children who have hypopituitarism, 5 were studiej before and after one year of human growth hormone (HGH) therapy and 5 were studied before treatment only. Basal and peak response CT levels were essentially unchanged by HGH. In the patients with hypopituitarism, CT levels increased from 41.9 * 5.1 pglml to a peak of 67.4 + 10 pglml after pentagastrin and from 38.8 + 5.2
pglml to a peak of 107 t 14.9 pglml after calcium infusion. In the cretins, CT levels increased from 33.8 t 6.5 pg/ml to 35.8 i 7 pg/ml following pentagastrin and from 31.4 t 5.9 pglml to 40 t 4.9 pglml following calcium. Although basal levels of CT seemed to be lower in cretins, these values could not be rigorously validated. The patients with l~ypopituitarism had greater CT responses than the cretins, especially to calcium infusion. These studies suggest that children with hypopituitarism have a greater CT response to calcium infusion than do normal adults and that CT secretion is abnormal in patients with athyrrotic cretinism.
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Eight sickle cell patients, 9-15 yr., with severe growth retardation, retarded bone age and delayed puberty had normal serum concentrations of T4,T3,PRL after chlorpromazine stimulation, and normal adrenal functions measured by circadian variation of plasma cortisol, plasma cortisol during hypoglycemia, ACTH and metyrapone tests. hGH response to insulin-induced hypoglycemia was abnormally low in 4/8. Four males and 3 females had elevated plasma concentrations o f LH and FSH; 4 males had low plasma testosterone and 3 females had low plasma estradiol. The severe growth retardation seems to result from a primary gonadal hypofunction associated in some cases with hGH deficiency.
Ethylestrenol, a synthetic androgen, was administered for one year at 2 to 4 mg daily. Range of growth rate before therapy was 1.2-4.9 cmlyr; during therapy was 3.6-15.6 cm/yr. There was no acceleration in bone age. No significant changes in Hgb., Hct., reticulocyte count and fetal Hgb occurred. A striking finding was a consistent increase in red cell mass measured by 5lCr tagging of the RBC. There was a tendency towards a further shortening of an already short 5 1~r RBC survival in 4/6. There were no consistent changes in an already very low plasma 5 9~e disappearance rate. Ethylestrenol, was found to stimulate growth without accelerating bone maturation, and to increase red cell mass without prolonging red cell survival. Normal adrenal and adrenal tumor cells from a female infant with a virilizing adrenal tumor were grown in tissue culture for a period of 7 weeks with and without ACTH (0.1 unitlml). The cells grew well and continued to produce steroid hormones, as measured by radioimmunoassay of individual steroids in the culture medium. Compared to normal cells, tumor cells with no ACTH added produced equivalent amounts of cortisol, 180H corticosterone, and 180H deoxycorticosterone, but lesser amounts of dehydro. epiandosterone (DHA), androstenedione (A), testosterone (T) and progesterone. Normal cells exposed to ACTH showed an increase in all steroids measured whereas ACTH-exposed tumor cells showed an -increase principally in DHA, consistent with a deficiency in 3fl-hydroxysteroid dehydrogenase. Concentrations of DHA, A and T in the patient's serum were elevated before the adrenal tumor was removed. The relative concentration of the three androgens in media of tumor cells in vitro resembled that in patient's serum in vivo. These studies demonstrate that both normal and tumor cells of adrenal can be maintained for a long time in vitro, that they retain their ability to respond to ACTH and that they produce their characteristic steroids. The tumor cells appear to have a 36-hydroxysteroid dehydrogenase deficiency.
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The peripheral retaholisn of T! lta? '\ecn note4 to l,r .-Itarc*,' in a number of non-thvrof~lal illnr.;ses. The known relationsl>lp of thyroid hormones and oxvgen consumption 1c.d to tl~csc' .;tuc'ic.s investlpatinr the rfrects of 11vnn"in or: nr-rin'lcral i-rla!l~lli-n n r TI,. T!,,T?, rT7 ancl TCII levels vrrr i1ctcrminr<! in nati~.nls *:it1. status astl~mnticl~s 1r:l cv;anotic Ilcnrt ,lisf.nqr, none rrf 5.l1lor !d(-rc. cacliec tic or rmlnol~ris'r~~,l. 'lean rrsi~l ts !+S1"') Ire. tal~~tlate~l ',cloii "0" T,s T rT 7 . I n'.7+h.l 77.7tk.1 1.77!.'" There 4.3s 3 sirnificant J e c r~n ' i~ in T-, level9 ,<it11 a ~iypiqi-cant incrca?~ in rT7 in the natirnt? (.it11 c'lrnnic 'ivyn.tln. i'vrn hvnoxin of short drsration cause+ n si~nificnnt incrrnsr In rT1 T4 levels were also lower in thc r'lronic livnoxir protln. Tl~esr data are similar to the finrlincs n!,tni.re~! dr~rinp ratnhnlic nnnthvroi(la1 illnesses. Tbese alteration? in t1l..rnlJ f~~nction taxc:tc mav reflect an adantivr n'lenorenon at tl!r CCI 1111,~r level, 1 .r. .:
nrotertive mechanism which can dfvrrt T ! , to rT,, or ronvers~lv, nn during cold exposure, can Inrrcasr nrndrjction of Tv Tn Ilrht of these dnt.? correlntinp 'lvnoxin and thvroir' I>nrmnneq. the stir~estions that the low thvroid function levrls in 99s lnfnnts ma\ be etiolo~icnllv relatefi to 'l?S rnnv nee6 to he rrrvaluntcd.
